Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04236258 · ClinicalTrials.gov registry record · Phase 4
Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period
A Phase 4 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 94
- Enrollment target
NCT04236258 is a Phase 4 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 94 participants.
The verdict
NCT04236258, a Phase 4 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 94 participants
- Enrollment target
Study Summary
This study evaluates whether nifedipine or enalapril is better at decreasing the amount of medical resources used in the postpartum period by women who have high blood pressure in pregnancy and the postpartum period. Half of participants will receive enalapril while the other half will receive enalapril. We will compare the two groups in the amount of medical resources used which we are defining as prolonged hospitalizations, unscheduled medical visits and/or hospital readmissions in the postpartum period.
Interventions
- DRUG NIFEdipine ER
- DRUG Enalapril
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2020-01-24 |
| Est. Completion | 2021-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04236258
The ClinicalTrials.gov registry entry for NCT04236258 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NIFEdipine ER is the first listed.
NCT04236258 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04236258 about?
NCT04236258 is a clinical study titled "Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period". This study evaluates whether nifedipine or enalapril is better at decreasing the amount of medical resources used in the postpartum period by women who have high blood pressure in pregnancy and the postpartum period. Half of participants will receive enalapril while the other half will receive enala...
What is the current status of trial NCT04236258?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 94 participants. The study started on 2020-01-24. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT04236258?
The interventions under investigation include: NIFEdipine ER (DRUG), Enalapril (DRUG).
Who is sponsoring clinical trial NCT04236258?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.